98%
921
2 minutes
20
Background: A growing number of older adults exhibit neurofibrillary tangle pathology without significant amyloid deposition, a biomarker profile consistent with suspected non-Alzheimer's pathophysiology or primary age-related tauopathy. The cognitive consequences within this subgroup remain poorly characterized, particularly with respect to vascular comorbidity. This study investigates whether vascular neuropathologies are associated with pre-mortem cognitive decline among individuals with predominately neurofibrillary tangles and low to none neuritic plaque pathology detected post-mortem.
Methods: The sample included autopsy-confirmed data from 579 participants in the National Alzheimer's Coordinating Center (NACC) cohort with intermediate-to-high Braak stage (B2-B3) and absent or minimal neuritic plaques (C0-C1). Vascular neuropathologies included arteriolosclerosis, atherosclerosis of the circle of Willis, gross infarcts/ lacunes, and microinfarcts were assessed for associations with global cognition (Clinical Dementia Rating Sum of Boxes, CDR-SOB) and harmonized cognitive domain specific performance (memory, executive function, and language) using multivariable regression adjusted for age, sex, education, and apolipoprotein ε4 status. Sensitivity analyses further controlled for cardiovascular risk, excluded individuals with any neuritic plaques, and controlling for individual neuritic plaque and Braak staging.
Results: Cross-sectionally, microinfarcts were consistently associated with poorer memory (β = - 0.28, p = 0.02), executive function (β = - 0.24, p = 0.02), and language (β = - 0.21, p = 0.02) approximate to death. Gross infarcts were associated with language impairment and higher CDR scores. These associations remained significant after adjusting for cardiovascular risk and were even stronger when restricted to strictly neuritic amyloid negative individuals.
Conclusions: Microinfarcts may represent a key driver of cognitive impairment in neurofibrillary tangle predominant individuals. These findings highlight a vascular-neurodegenerative pathway that warrants consideration in non-neuritic plaque models of cognitive decline and may inform targeted prevention strategies.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12288546 | PMC |
http://dx.doi.org/10.21203/rs.3.rs-7036276/v1 | DOI Listing |
J Alzheimers Dis
September 2025
IRCCS Fondazione Don Carlo Gnocchi ONLUS, Milan, Italy.
The "biological view" of Alzheimer's disease (AD) focuses on the role of plaques and tangles and excludes syndromes from the disease definition. However, cognitive syndromes are fundamental aspects of AD and are the ultimate target of treatments. Accordingly, the study of cognitive syndromes should remain a major goal of AD research.
View Article and Find Full Text PDFPsychogeriatrics
September 2025
Clinical Neurosciences and Mental Health Department, Faculty of Medicine of Porto University, Porto, Portugal.
The dopaminergic system may be at the base of some neurobehavioral symptoms, as apathy and depression, and extrapyramidal symptoms, often seen in Alzheimer's disease patients. It can also have an impact on cognitive decline, as extrapyramidal symptoms, classically linked with dopamine dysfunction, are associated with increased risk of cognitive impairment and Alzheimer's disease progression. We review the knowledge of the dopaminergic system, emphasizing changes in Alzheimer's disease.
View Article and Find Full Text PDFACS Sens
September 2025
Department of Pharmacy, The People's Hospital of Guangxi Zhuang Autonomous Region & Guangxi Academy of Medical Sciences, Nanning, Guangxi 530021, China.
Alzheimer's disease (AD) is a progressive neurodegenerative disorder primarily characterized by cognitive decline and behavioral impairments, typically manifesting in the elderly and presenile population. With the rapid global aging trend, early diagnosis and treatment of AD have become increasingly urgent research priorities. The primary pathological features of AD include excessive accumulation of β-amyloid (Aβ) plaques, the formation of neurofibrillary tangles, and neuronal loss.
View Article and Find Full Text PDFJ Integr Neurosci
August 2025
CIBA Center for Advanced Biomedical Research, School of Medicine, Autonomous University of Queretaro, 76010 Querétaro, México.
Background: Neurofibrillary tangles, composed of hyperphosphorylated tau, have been implicated in the cognitive impairments observed in Alzheimer's disease. While the precise mechanism remains elusive, cognitive deficits in Alzheimer's disease have been associated with disrupted brain network activity. To investigate this mechanism, researchers have developed several tau transgenic models.
View Article and Find Full Text PDFTurk J Biol
June 2025
Department of Biochemistry, School of Pharmacy, Hacettepe University, Ankara, Turkiye.
Background/aim: Tau protein, which is crucial for sustaining the cytoskeletal network by assisting microtubule construction, contributes significantly to the pathophysiology of Alzheimer's disease (AD). The hyperphosphorylation of tau causes it to detach from microtubules (MTs), leading to the formation of neurofibrillary tangles (NFTs) in neurons, which ultimately results in cell death. Thionine (TH), a cationic phenothiazine-structured compound, has been the topic of extensive research due to its interesting physicochemical properties.
View Article and Find Full Text PDF